MeSH D012874 - infectious skin diseases
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D012874:Â
Infectious skin diseases
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| 3M | Chlorhexidine | Avagard |  | 2001-06-07 |  |  |
| Chlorhexidine | Peridex |  | 1986-08-13 |  |  | |
| Chlorhexidine | Soluprep | 2029-07-26 | 2018-08-08 |  |  | |
| AbbVie | Dalbavancin | Xydalba |  | 2015-02-19 |  |  |
| Ceftaroline fosamil | Teflaro | 2030-09-21 | 2010-10-29 |  |  | |
| Dalbavancin | Dalvance | 2023-11-14 | 2014-05-23 |  |  | |
| Accord Healthcare | Tigecycline | Tigecycline Accord |  | 2020-04-17 |  |  |
| Alembic Pharmaceuticals | Azithromycin | Azithromycin |  | 2020-01-28 |  |  |
| Amneal Pharmaceuticals | Azithromycin | Azithromycin |  | 2018-07-19 |  |  |
1
2
3
4
5
6
...
10
>
Clinical Trials
Historical Success Rate
Phase 1
0%0/0
Phase 2
88%7/8
Phase 3
51%20/39
Approved: 17Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
5
6
7
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use